Skip to content

Comparative analysis of Dietary Supplement vs Analgesic in managing pain after wisdom tooth removal

Comparative evaluation of Palmitoylethanolamide (PEA) vs Ketorolac in Pain management after Third Molar Surgery A Randomised Controlled Study - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072195
Enrollment
80
Registered
2024-08-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K011- Impacted teeth

Interventions

Intervention1: Palmitoylethanolamide: Palmitoylethanolamide 300mg BD x 5 days Control Intervention1: Ketorolac: Ketorolac 10mg QID x 5 days

Sponsors

Hemang Kapoor
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged between 18 to 40 under going 3rd molar extraction. No systemic disease. Healthy human volunteer. Does not smoke or consume any substance that interferes with study.

Exclusion criteria

Exclusion criteria: Patients with known allergies to Palmitoylethanolamide or Ketorolac. History of gastrointestinal ulcers, renal or hepatic impairment. Pregnant woman and lactating mother.

Design outcomes

Primary

MeasureTime frame
Pain intensity as measured by VAS scores at 24 and 48 hours post-surgery. Timepoint: Pain intensity as measured by VAS scores at 24 and 48 hours post-surgery.

Secondary

MeasureTime frame
Total consumption of rescue medication. Patient satisfaction scores. Incidence of adverse events Functional outcomes such as the ability to return to normal activities Timepoint: Patient satisfaction scores to be checked at 7th & 14th day.

Countries

India

Contacts

Public ContactHemang Kapoor

Manav Rachna Dental College

nitinbhagat.sds@mrei.ac.in9953784571

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026